Key facts
- Notable investors include Hangzhou Shenghui Jingchen Investment Management, Homsun Capital, Royal Sunward Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Shanghai Quitedi Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Shanghai Quitedi Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shanghai Quitedi Biotechnology
Provider of advanced biotechnology solutions designed to facilitate drug discovery and development. The company offers state-of-the-art bioassay technologies, enabling pharmaceutical companies to streamline their research and bring innovative therapies to market efficiently.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Website
- quietdbio.com/
- Ownership
- Privately Held (backing)
Shanghai Quitedi Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shanghai Quitedi Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shanghai Quitedi Biotechnology in its N-PORT filings yet. We sweep new filings monthly.